Junne Kamihara, MD, PhD of Dana-Farber Cancer Institute explains the significance of the shift from single gene testing to multiplex testing.This was recorded at ASCO’s 2017 Cancer Survivorship Symposium in San Diego, CA.
Advertisement
Significance of Shift from Single Gene Testing to Multiplex Testing
